MYD88 and B-cell chronic lymphocytic leukemia: There were no differences in the expression of MYD88 in ZAP-70+ CLL patients compared to ZAP-70− with a median 0.1734 vs. 0.1816 (p = 0.6426) in PBMC and BMMC with a median 0.1646 vs. 0.1601 (p = 0.9589).